CBJ

Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session

CBJ Newsmakers

Celestica and AMD Announce Collaboration to Advance the Next Era of AI with “Helios” Rack-Scale AI Platform

CBJ Newsmakers

Beyond Oil Becomes Approved Vendor of Premium Casual Dining Chain in the United States

CBJ Newsmakers

Maxus Mining Confirms Strong Polymetallic Results at the Quarry Antimony Property in British Columbia, Canada

CBJ Newsmakers

Extendicare Announces March 2026 Dividend of C$0.0441 per Share

CBJ Newsmakers

Asante Provides Operations Update

CBJ Newsmakers

Bombardier Commences Consent Solicitations with Respect to its 7.35% Debentures due 2026 and its 7.450% Notes due 2034

CBJ Newsmakers

DPM Metals Announces Renewal of Normal Course Issuer Bid

CBJ Newsmakers

POET Technologies and LITEON Announce Joint Development of Optical Modules for AI Applications

CBJ Newsmakers

Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial

CBJ Newsmakers